Fangling Tao

Fangling Tao is a highly experienced biostatistician with extensive expertise in statistical analysis for clinical trials, particularly within the medical device and oncology sectors. Currently serving as a Principal Biostatistician at Edwards Lifesciences, Fangling has a robust background in developing and validating study protocols, statistical analysis plans, and SAS programming for various clinical trials, including projects for FDA submissions. Previous roles include Principal Statistician at AstraZeneca, where Fangling focused on quality control in oncology studies, and Senior Statistician at Celgene, where responsibilities included designing data collection criteria and performing complex statistical analyses. With advanced degrees in Mathematics, Statistics, and Entomology, Fangling possesses a solid foundation in both theoretical and applied statistics.